Both medications are effective tools for weight management when combined with lifestyle modifications, and the choice should be tailored to your individual needs and circumstances
Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults
Significant weight loss may raise endogenous testosterone in those with obesity-related hypogonadism, sometimes allowing TRT dose reduction
Wegovy also contains warnings for: Wegovy is likely indicating a new generation of hormonal medications for chronic weight management that are more effective for weight-loss and improvement in cardiovascular risk factors
"Novo Nordisk has always worked to secure affordable access to our innovative medicines, and today's announcement will bring semaglutide medicines to more American patients at a lower cost, Importantly, this also expands obesity medication access in Medicare, which will allow people living with obesity to access authentic Wegovy."
To view a copy of this licence, visit About this article Cite this article Jia, J., Liu, Y., Wang, D
